Replies to post #79 on Revance Therapeutics Inc (RVNC)

[north40000]

There are those who think injectable will/would be more valuable.

[kris_kade]

R/r is high now with RT001 and TransMTS failure.

Company not disclosing P3 trail data for RT001 fully is a big red flag. Commercial timeline for RT001 is far away that no hurry buying now.

Management got their priorities between RT001 & 2 wrong and now the so called TransMTS MOD may be questionable as they use this for injectable too.